Why is Zortrax SA ?
- The company has reported losses. Due to this company has reported negative ROE
- Poor long term growth as Operating profit has grown by an annual rate -232.41% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -5.60
- The company has reported losses. Due to this company has reported negative ROE
- NET SALES(HY) At PLN 0.72 MM has Grown at -68.78%
- ROCE(HY) Lowest at -259.93%
- RAW MATERIAL COST(Y) Grown by 138.6% (YoY)
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -18.56%, its profits have risen by 51.4%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Zortrax SA for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at PLN -0.21 MM
Highest at PLN -0.11 MM
At PLN 0.72 MM has Grown at -68.78%
Lowest at -259.93%
Grown by 138.6% (YoY
Highest at 544.16 %
Lowest at 2.59 times
Lowest at 1.14 times
Lowest at PLN -6.86 MM
Lowest at PLN -6.85 MM
Lowest at PLN -0.04
Here's what is working for Zortrax SA
Operating Cash Flows (PLN MM)
Operating Profit (PLN MM)
Here's what is not working for Zortrax SA
Net Sales (PLN MM)
Pre-Tax Profit (PLN MM)
Net Profit (PLN MM)
Pre-Tax Profit (PLN MM)
Net Profit (PLN MM)
EPS (PLN)
Debt-Equity Ratio
Inventory Turnover Ratio
Debtors Turnover Ratio
Raw Material Cost as a percentage of Sales






